Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis.

Oliver C CohenAnanth SathyanathAviva PetrieSriram RavichandranSteven LawRicha ManwaniDarren FoardSajitha SachchithananthamShameem MahmoodAna Martinez-NaharroMarianna FontanaCarol J WhelanPhilip N HawkinsHelen J LachmannJulian D GillmoreAshutosh D Wechalekar

Published in: Heart (British Cardiac Society) (2022)

The 6MWT is prognostic in AL amyloidosis. A baseline distance of ≥350 m independently predicts better survival. These data suggest that 6MWT has utility in AL amyloidosis for baseline prognosis and assessing response.

Keyphrases

multiple myeloma
electronic health record
machine learning
free survival
deep learning
artificial intelligence
data analysis